Home Tags NASDAQ:AKBA

Tag: NASDAQ:AKBA

Akebia Therapeutics Inc. (NASDAQ: AKBA) Amends and Restates Terms of Agreement...

Kate Hudson - 0

Akebia Therapeutics Inc. (NASDAQ: AKBA) Says District Court Has Rejected CMS’s...

Gavins Felicity - 0

Akebia Therapeutics Inc. (NASDAQ: AKBA) Will Present Vadadustat Safety And Efficacy...

Matt Wade - 0

Akebia Therapeutics Inc (NASDAQ:AKBA) Will Post Q1 2021 Revenues On May...

Kate Hudson - 0

Akebia Therapeutics Inc (NASDAQ:AKBA) Files NDA With The US FDA For...

Ward Sport - 0
123Page 1 of 3

Recent Post

Pfizer’s (NYSE: PFE) Ponsegromab Shows Promise in Fighting Cancer Cachexia

Gavins Felicity - 0
Pfizer (NYSE: PFE) recently announced positive results from a midstage trial of their experimental drug, ponsegromab, designed to treat cancer cachexia, a...

Singular Genomics (OMIC) Receives Buyout Offer, Stock Soars

Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal

Summit Therapeutics Secures $235 Million in Funding from Leading Biotech Investors

Monopar Therapeutics’ (MNPR) MNPR-101-Zr Shows Promising Tumor Targeting in Early Clinical...

© BioPharma Journal 2020